AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19819688 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (Group B)
Number of subjects: 108
Study 18977646 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate/formoterol combination via single inhaler
Number of subjects: 645
Study 18977646 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate/formoterol combination via separate inhalers
Number of subjects: 645
Study 18977646 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (500 microg bid) via CFC pMDI
Number of subjects: 645
Study 18977646 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (500 microg bid) via CFC pMDI and formoterol (12 microg bid) via DPI
Number of subjects: 645
Study 16979990 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA‐everolimus‐based regimen
Number of subjects: 12
Study 16979990 — intervention group
Group type: COMPARATOR
Intervention: CsA‐azathioprine‐based regimen
Number of subjects: 12
Study 13678928 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (10 IU)
Number of subjects: 18
Study 13678928 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 18
Study 11003253 — intervention group
Group type: EXPERIMENTAL
Intervention: Human ultralente insulin injected at 17.00 h
Number of subjects: 10
Study 11003253 — intervention group
Group type: EXPERIMENTAL
Intervention: Human ultralente insulin injected at 22.00 h
Number of subjects: 10
Study 11003253 — intervention group
Group type: COMPARATOR
Intervention: Regular insulin injected before dinner
Number of subjects: 10
Study 11003253 — intervention group
Group type: EXPERIMENTAL
Intervention: Human ultralente insulin (in general)
Number of subjects: 10
Study 8671110 — intervention group
Group type: EXPERIMENTAL
Intervention: Different recruitment strategies
Number of subjects: 0
Study 8671110 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 0
Study 8671110 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial completion
Number of subjects: 0
Study 8671110 — intervention group
Group type: EXPERIMENTAL
Intervention: Early trial dropout
Number of subjects: 0
Study 1345332 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol reduction (approximately 5%)
Number of subjects: 0
Study 6418897 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical chemotherapy (thiotepa or VM26)
Number of subjects: 123
Study 6418897 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection alone
Number of subjects: 123
Study 30888448 — intervention group
Group type: EXPERIMENTAL
Intervention: All-inside technique with ST4 autograft
Number of subjects: 90
Study 30888448 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique with ST/G autograft
Number of subjects: 90
Study 29742264 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.12% mouthwash (CHX)
Number of subjects: 822
Study 29742264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 822
Study 25822598 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (techniques chosen by surgeons)
Number of subjects: 250
Study 25822598 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment (initial sling immobilization followed by active rehabilitation)
Number of subjects: 250
Study 25822598 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 250
Study 25822598 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 250
Study 24023786 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg
Number of subjects: 72
Study 24023786 — intervention group
Group type: COMPARATOR
Intervention: ezetimibe 10 mg
Number of subjects: 72
Study 24023786 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg and ezetimibe 10 mg combination
Number of subjects: 72
Study 21774281 — intervention group
Group type: EXPERIMENTAL
Intervention: Special education group
Number of subjects: 200
Study 21774281 — intervention group
Group type: COMPARATOR
Intervention: Routine education group
Number of subjects: 200
Study 19002384 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 100 mg plus mFOLFOX6
Number of subjects: 17
Study 19002384 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg plus mFOLFOX6
Number of subjects: 17
Study 17255230 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (900 mg/d)
Number of subjects: 35
Study 17255230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 15599989 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus
Number of subjects: 0
Study 15599989 — intervention group
Group type: COMPARATOR
Intervention: Excipient
Number of subjects: 0
Study 15599989 — intervention group
Group type: COMPARATOR
Intervention: Moderately active topical corticosteroids
Number of subjects: 0
Study 15599989 — intervention group
Group type: COMPARATOR
Intervention: Topical corticosteroids
Number of subjects: 0
Study 11740820 — intervention group
Group type: COMPARATOR
Intervention: Neovastat in addition to induction chemotherapy/radiotherapy
Number of subjects: 482
Study 11740820 — intervention group
Group type: COMPARATOR
Intervention: Neovastat as a monotherapy
Number of subjects: 482
Study 11740820 — intervention group
Group type: EXPERIMENTAL
Intervention: Neovastat
Number of subjects: 482
Study 7620239 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline (5 mg)
Number of subjects: 6
Study 7620239 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (5 mg)
Number of subjects: 6
Study 7620239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 2836651 — intervention group
Group type: EXPERIMENTAL
Intervention: hCRF (2 micrograms/kg body weight) with naloxone (1.6 mg i.v. bolus, followed by an infusion at a rate of 1.2 mg/h)
Number of subjects: 6
Study 2836651 — intervention group
Group type: EXPERIMENTAL
Intervention: hCRF alone
Number of subjects: 6
Study 2836651 — intervention group
Group type: COMPARATOR
Intervention: hCRF with naloxone
Number of subjects: 6
Study 29847831 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral analysis system of psychotherapy (CBASP)
Number of subjects: 1036
Study 29847831 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant pharmacotherapy
Number of subjects: 1036
Study 29847831 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (CBASP + pharmacotherapy)
Number of subjects: 1036
Study 29847831 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (either CBASP or pharmacotherapy)
Number of subjects: 1036
Study 28802440 — intervention group
Group type: EXPERIMENTAL
Intervention: Debiasing technique 'considering the alternative'
Number of subjects: 0
Study 26167944 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibliotherapy with therapist support
Number of subjects: 89
Study 26167944 — intervention group
Group type: COMPARATOR
Intervention: Bibliotherapy without therapist support
Number of subjects: 89
Study 23540233 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-tobacco educational programme
Number of subjects: 859
Study 23540233 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational actions)
Number of subjects: 859
Study 21508655 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-microdebrider-assisted inferior turbinoplasty (PAT)
Number of subjects: 46
Study 21508655 — intervention group
Group type: COMPARATOR
Intervention: Submucosal resection (SMR)
Number of subjects: 46
Study 18294229 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic mechanical instrumentation (UMI) with chlorhexidine (CHX) 0.02%
Number of subjects: 19
Study 18294229 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic mechanical instrumentation (UMI) alone
Number of subjects: 19
Study 16549259 — intervention group
Group type: EXPERIMENTAL
Intervention: Headache Impact Test (HIT) administered at baseline and 6-week follow-up
Number of subjects: 71
Study 16549259 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients reporting 'somewhat better' change
Number of subjects: 71
Study 16549259 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients reporting no change
Number of subjects: 71
Study 16549259 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum important difference (MID) estimation
Number of subjects: 71
Study 14596323 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg citrate
Number of subjects: 46
Study 14596323 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg amino-acid chelate
Number of subjects: 46
Study 14596323 — intervention group
Group type: COMPARATOR
Intervention: Mg oxide
Number of subjects: 46
Study 11029398 — intervention group
Group type: COMPARATOR
Intervention: VEGF-A(165), VEGF-A(189), VEGF-B, VEGF-R(1) mRNA and protein levels in DCM patients
Number of subjects: 0
Study 11029398 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF-C mRNA and protein levels in ICM patients
Number of subjects: 0
Study 11029398 — intervention group
Group type: COMPARATOR
Intervention: Capillary density in DCM patients
Number of subjects: 0
Study 11029398 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary density in ICM patients
Number of subjects: 0
Study 11029398 — intervention group
Group type: COMPARATOR
Intervention: Collagen levels in DCM patients
Number of subjects: 0
Study 11029398 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscular hypertrophy in DCM and ICM patients
Number of subjects: 0
Study 9715552 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily gentamicin regimen (4 mg/kg Q 24 h)
Number of subjects: 18
Study 9715552 — intervention group
Group type: COMPARATOR
Intervention: Conventional gentamicin regimen (2.5 mg/kg Q 12 h)
Number of subjects: 18
Study 8285548 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of 0.25% bupivacaine
Number of subjects: 60
Study 8285548 — intervention group
Group type: COMPARATOR
Intervention: 20 ml of saline
Number of subjects: 60
Study 3543234 — intervention group
Group type: EXPERIMENTAL
Intervention: MTC plus P
Number of subjects: 200
Study 3543234 — intervention group
Group type: COMPARATOR
Intervention: MTC alone
Number of subjects: 200
Study 29361197 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on structured goal-planning and supportive telephone follow-up rehabilitation program
Number of subjects: 389
Study 29361197 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation
Number of subjects: 389
Study 27367263 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment 'failures' (heavy drinkers) in COMBINE
Number of subjects: 2490
Study 27367263 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment 'failures' (heavy drinkers) in Project MATCH
Number of subjects: 2490
Study 27367263 — intervention group
Group type: COMPARATOR
Intervention: Treatment 'successes' (non-heavy drinkers)
Number of subjects: 2490
Study 26042037 — intervention group
Group type: COMPARATOR
Intervention: 250 mg cocoa supplementation (acute)
Number of subjects: 40
Study 26042037 — intervention group
Group type: COMPARATOR
Intervention: 250 mg cocoa supplementation (sub-chronic)
Number of subjects: 40
Study 26042037 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 40
Study 23816723 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril (5-40 mg/day)
Number of subjects: 137
Study 23816723 — intervention group
Group type: EXPERIMENTAL
Intervention: Dioscorea bulbifera (500 mg BD)
Number of subjects: 137
Study 23816723 — intervention group
Group type: COMPARATOR
Intervention: Control (neither drug)
Number of subjects: 137
Study 20085544 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 10 microg/kg
Number of subjects: 465
Study 20085544 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg/kg
Number of subjects: 465
Study 20085544 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 465
Study 18720882 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone combined with conventional methods
Number of subjects: 84
Study 18720882 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone injection combined with conventional methods
Number of subjects: 84
Study 18720882 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injection via external ear combined with conventional methods
Number of subjects: 84
Study 18720882 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injection via pharyngotympanic tube combined with conventional methods
Number of subjects: 84
Study 16051416 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (2 mg or 4 mg i.v.) combined with oxytocin
Number of subjects: 107
Study 16051416 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with oxytocin
Number of subjects: 107
Study 12787540 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin and aspirin
Number of subjects: 0
Study 11093393 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg three times daily for five days
Number of subjects: 174
Study 11093393 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 500 mg with codeine 30 mg six hourly for 5 days
Number of subjects: 174
Study 8994559 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive psychosocial research protocol
Number of subjects: 169
Study 8994559 — intervention group
Group type: COMPARATOR
Intervention: Non-recovered group (NR)
Number of subjects: 169
Study 8994559 — intervention group
Group type: COMPARATOR
Intervention: Recovered group (R)
Number of subjects: 169
Study 8402763 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 28
Study 8402763 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 28
Study 8402763 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy, normotensive)
Number of subjects: 28
Study 3957487 — intervention group
Group type: EXPERIMENTAL
Intervention: Deriphyllin-Digoxin tablets
Number of subjects: 14
Study 3957487 — intervention group
Group type: COMPARATOR
Intervention: Lanoxin
Number of subjects: 14
Study 31965610 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical management (placement of a single 3.5-mm lag screw under arthroscopic guidance)
Number of subjects: 47
Study 31965610 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 47
Study 30286028 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal model
Number of subjects: 46
Study 30286028 — intervention group
Group type: COMPARATOR
Intervention: Blue Phantom models
Number of subjects: 46
Study 27237088 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring wires attached (with electrodes)
Number of subjects: 228
Study 27237088 — intervention group
Group type: COMPARATOR
Intervention: No monitoring wires attached (without electrodes)
Number of subjects: 228
Study 25313586 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS group (n=195)
Number of subjects: 388
Study 25313586 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=193)
Number of subjects: 388
Study 22137686 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 30
Study 22137686 — intervention group
Group type: COMPARATOR
Intervention: Conventional petroleum gauze dressings (conv)
Number of subjects: 30
Study 20720134 — intervention group
Group type: COMPARATOR
Intervention: Standard LPS-Flex prosthesis
Number of subjects: 85
Study 20720134 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender-specific LPS-Flex prosthesis
Number of subjects: 85
Study 20720134 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study 18569991 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 139
Study 18569991 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous ethanol injection (PEI)
Number of subjects: 139
Study 15661109 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg bodyweight)
Number of subjects: 11
Study 15661109 — intervention group
Group type: COMPARATOR
Intervention: Placebo (decaffeinated coffee)
Number of subjects: 11
Study 12614748 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 28
Study 10232640 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgalactooligosaccharides 15 g/d
Number of subjects: 40
Study 10232640 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgalactooligosaccharides 7.5 g/d
Number of subjects: 40
Study 10232640 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 g/d)
Number of subjects: 40
Study 8966163 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid urease‐based test
Number of subjects: 150
Study 8966163 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture
Number of subjects: 150
Study 8966163 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological staining
Number of subjects: 150
Study 8966163 — intervention group
Group type: EXPERIMENTAL
Intervention: Serology
Number of subjects: 150
Study 1813313 — intervention group
Group type: EXPERIMENTAL
Intervention: summarization training
Number of subjects: 45
Study 1813313 — intervention group
Group type: EXPERIMENTAL
Intervention: summarization training with a self-monitoring component
Number of subjects: 45
Study 1813313 — intervention group
Group type: COMPARATOR
Intervention: traditional instruction
Number of subjects: 45
Study 6337425 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 1000 mg daily
Number of subjects: 203
Study 6337425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 30507211 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally accommodated treatment (A-CBT)
Number of subjects: 70
Study 30507211 — intervention group
Group type: COMPARATOR
Intervention: Standard group-based cognitive-behavioral treatment (S-CBT)
Number of subjects: 70
Study 29503404 — intervention group
Group type: COMPARATOR
Intervention: Pitavastatin 1 mg/day
Number of subjects: 12600
Study 29503404 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg/day
Number of subjects: 12600
Study 27228270 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 27228270 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Acupuncture
Number of subjects: 0
Study 27228270 — intervention group
Group type: COMPARATOR
Intervention: Conventional Care (Control)
Number of subjects: 0
Study 24008122 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine combination therapy (150mg aliskiren + 5mg amlodipine for 8 weeks, then 300mg aliskiren + 5mg amlodipine for another 8 weeks)
Number of subjects: 105
Study 24008122 — intervention group
Group type: COMPARATOR
Intervention: High-dose amlodipine monotherapy (10mg amlodipine for 16 weeks)
Number of subjects: 105
Study 22925922 — intervention group
Group type: EXPERIMENTAL
Intervention: Locator attachment
Number of subjects: 0
Study 22925922 — intervention group
Group type: EXPERIMENTAL
Intervention: Magfit attachment
Number of subjects: 0
Study 20036363 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day (early intensive lipid-lowering therapy)
Number of subjects: 180
Study 20036363 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 180
Study 18580483 — intervention group
Group type: COMPARATOR
Intervention: PEEP 0 mbar
Number of subjects: 39
Study 18580483 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 5 mbar
Number of subjects: 39
Study 18580483 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 10 mbar
Number of subjects: 39
Study 16205071 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept
Number of subjects: 69
Study 11845337 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization (physiotherapy)
Number of subjects: 168
Study 11845337 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (soft cervical collar)
Number of subjects: 168
Study 10430396 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy (Pantoprazole 40 mg daily, Amoxycilline 1000 mg b.i.d., Clarithromycine 500 mg b.i.d.)
Number of subjects: 251
Study 10430396 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy
Number of subjects: 251
Study 7638662 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiologic findings
Number of subjects: 100
Study 7638662 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical findings
Number of subjects: 100
Study 7638662 — intervention group
Group type: EXPERIMENTAL
Intervention: Sagittal diameter changes
Number of subjects: 100
Study 7638662 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiologic subgroups of stenosis
Number of subjects: 100
Study 2178390 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta cooked for 11 min
Number of subjects: 12
Study 2178390 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta cooked for 16.5 min
Number of subjects: 12
Study 2178390 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta cooked for 22 min
Number of subjects: 12
Study 2178390 — intervention group
Group type: EXPERIMENTAL
Intervention: Methane producers
Number of subjects: 12
Study 2178390 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmethane producers
Number of subjects: 12
Study 6110818 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine given one month after hepatitis B immune globulin injection
Number of subjects: 60
Study 6110818 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine and immune globulin given simultaneously
Number of subjects: 60
Study 6110818 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B vaccine given alone
Number of subjects: 60
Study 31975547 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise (60 minutes)
Number of subjects: 10
Study 31975547 — intervention group
Group type: COMPARATOR
Intervention: Rest without food consumption
Number of subjects: 10
Study 29802172 — intervention group
Group type: EXPERIMENTAL
Intervention: Added angiographic embolisation
Number of subjects: 241
Study 29802172 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 241
Study 27745536 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped collaborative care intervention
Number of subjects: 115
Study 27745536 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion of CBT element homework assignments
Number of subjects: 115
Study 27745536 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 115
Study 26564292 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate in 70% alcohol
Number of subjects: 388